LUCD
Lucid Diagnostics Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.94
−1.23%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 5.4M | 4.7M | 4.3M | 2.4M | 377.0K |
| Cost of Revenue | 6.8M | 7.5M | 8.3M | 8.5M | 3.6M |
| Gross Profit | (1.4M) | (2.8M) | (3.9M) | (6.0M) | (3.2M) |
| Operating Expenses | |||||
| R&D Expense | 5.4M | 5.7B | 6.0M | 7.3M | 11.5M |
| SG&A Expense | 10.5B | 41.6B | 36.6B | 35.7M | 39.8M |
| General & Admin Expense | 5.4B | 23.9B | 20.2B | 19.3M | 23.7M |
| Selling & Marketing Expense | 5.0B | 17.7B | 16.5B | 16.4M | 16.1M |
| Other Expenses | (10.4B) | (47.2B) | (36.6B) | (478.0K) | 1.6M |
| Total Operating Expenses | 49.3M | 46.8M | 42.1M | 42.4M | 52.9M |
| Cost and Expenses | 56.1M | 54.3M | 50.4M | 50.9M | 56.5M |
| Operating Income (EBIT) | (50.7M) | (49.6M) | (46.1M) | (48.5M) | (56.2M) |
| Non-Operating | |||||
| Interest Income | 358.0K | 386.0K | 322.0K | 424.0K | 88.0K |
| Interest Expense | 18.0K | 22.0K | 26.0K | 416.0K | 8.0K |
| Net Interest Income | 340.0K | 364.0K | 296.0K | 8.0K | 80.0K |
| Other Non-Op Income/Expense | (1.6M) | (8.4M) | 523.0K | (4.2M) | — |
| Non-Operating Income (excl Interest) | 1.6M | 8.3M | (549.0K) | 3.8M | (8.0K) |
| EBT (Pre-Tax Income) | (52.3M) | (58.0M) | (45.5M) | (52.7M) | (56.2M) |
| Income Tax Expense | — | — | — | — | — |
| Bottom Line | |||||
| Net Income | (52.3M) | (58.0M) | (45.5M) | (52.7M) | (56.2M) |
| Earnings from Cont. Ops | (52.3M) | (58.0M) | (45.5M) | (52.7M) | (56.2M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (65.0M) | (70.6M) | (53.0M) | (52.7M) | (56.2M) |
| Per Share | |||||
| Basic EPS | ($0.47) | ($0.69) | ($1.05) | ($1.26) | ($1.55) |
| Diluted EPS | ($0.47) | ($0.69) | ($1.05) | ($1.26) | ($1.55) |
| Revenue Per Share | $0.03 | $0.05 | $0.09 | $0.06 | $0.01 |
| Shares | |||||
| Basic Shares Outstanding | 183.1M | 101.9M | 50.5M | 41.8M | 36.2M |
| Diluted Shares Outstanding | 183.1M | 101.9M | 50.5M | 41.8M | 36.2M |
| Profitability Metrics | |||||
| EBITDA | (51.4M) | (57.1M) | (44.3M) | (49.8M) | (54.2M) |
| D&A | 875.0K | 872.0K | 1.2M | 2.5M | 1.9M |
| EBIT | (52.2M) | (58.0M) | (45.5M) | (52.3M) | (56.2M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026